Pharma Equity Group A/S (OCSE:PEG) Operating Cash Flow per Share : kr-0.02 (TTM As of Mar. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Pharma Equity Group A/S Operating Cash Flow per Share?

Pharma Equity Group A/S's operating cash flow per share for the three months ended in Mar. 2024 was kr-0.01. Pharma Equity Group A/S's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was kr-0.02.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 63.60% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 32.90% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 39.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Pharma Equity Group A/S's Operating Cash Flow per Share or its related term are showing as below:

OCSE:PEG' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -89.9 Med: 29.95 Max: 86.2
Current: 63.6

During the past 13 years, Pharma Equity Group A/S's highest 3-Year average Operating Cash Flow per Share Growth Rate was 86.20% per year. The lowest was -89.90% per year. And the median was 29.95% per year.

OCSE:PEG's 3-Year OCF Growth Rate is ranked better than
95.71% of 1234 companies
in the Biotechnology industry
Industry Median: 3.35 vs OCSE:PEG: 63.60

Pharma Equity Group A/S Operating Cash Flow per Share Historical Data

The historical data trend for Pharma Equity Group A/S's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Equity Group A/S Operating Cash Flow per Share Chart

Pharma Equity Group A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.01

-0.31

-0.04

-0.02

Pharma Equity Group A/S Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	-0.01	-	-	-0.01

Competitive Comparison of Pharma Equity Group A/S's Operating Cash Flow per Share

For the Biotechnology subindustry, Pharma Equity Group A/S's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharma Equity Group A/S's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Equity Group A/S's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Pharma Equity Group A/S's Price-to-Operating-Cash-Flow falls into.

Pharma Equity Group A/S Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Pharma Equity Group A/S's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-16.624	/	1088.551
	=	-0.02

Pharma Equity Group A/S's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	-7.828	/	1039.497
	=	-0.01

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.02

Pharma Equity Group A/S Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Pharma Equity Group A/S's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Equity Group A/S (OCSE:PEG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Equity Group A/S (OCSE:PEG) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Slotsmarken 18, 2.th., Horsholm, DNK, DK-2970

Website

https://www.pharmaequitygroup.com

Pharma Equity Group A/S is an investment company specializing in the life science industry. The group is focused on an early investment in various life science companies that develops technologies and therapies that have the potential to improve human health and quality of life. The group specializes in early-stage investments in biotechnology, that are developing novel therapies for unmet medical needs. Its portfolio consists of companies dedicated to developing novel, effective treatments for diseases with patient and social impact for which current therapy is lacking or in need of improvement.